Invasive pneumococcal disease

Archives of Disease in Childhood: Education and Practice Edition

Volumn 96, Issue 5, 2011, Pages 183-190

  Randle, Elise ^a   Ninis, Nelly ^a   Inwald, David ^b  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM; CEFTRIAXONE; DEXAMETHASONE;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; HEALTH CARE ORGANIZATION; HUMAN IMMUNODEFICIENCY VIRUS; INVASIVE PROCEDURE; MORTALITY; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPHYLAXIS; SEIZURE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

CHILD; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MENINGITIS, PNEUMOCOCCAL; PEDIATRICS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; RISK FACTORS; SEPSIS; STREPTOCOCCUS PNEUMONIAE;

EID: 80052837250     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/adc.2010.191718     Document Type: Article

References (43)

1. Austrian R. Some aspects of the pneumococcal carrier state. J Antimicrob Chemother 1986;18(Suppl A):35-45. (Pubitemid 16038221)
2. National Collaborating Centre for Women's and Children's Health. Feverish illness in children: assessment and initial management in children younger than 5 years. London: NICE, 2007. http://www.nice.org.uk (accessed 29 Nov 2010).
3. American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000;106:362-6.
4. Pneumococcal infections. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red book: 2009 report of the Committee on Infectious Diseases. 28th edition. Elk Grove Village, IL: American Academy of Pediatrics 2009:524-35.
5. Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009;360:244-56.
6. Harboe ZB, Thomsen RW, Riis A, et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 2009;6:e1000081.
7. Davison KL, Ramsay ME. The epidemiology of acute meningitis in children in England and Wales. Arch Dis Child 2003;88:662-4. (Pubitemid 36930298)
8. Arditi M, Mason EO Jr, Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998;102:1087-97. (Pubitemid 28511715)
9. Chaudhuri A, Martinez-Martin P, Martin PM, et al.; EFNS Task Force. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 2008;15:649-59. (Pubitemid 351814425)
10. Rennick G, Shann F, de Campo J. Cerebral herniation during bacterial meningitis in children. BMJ 1993;306:953-5. (Pubitemid 23100014)
11. Joffe AR. Lumbar puncture and brain herniation in acute bacterial meningitis: a review. J Intensive Care Med 2007;22:194-207. (Pubitemid 47094113)
12. National Collaborating Centre for Women's and Children's Health. Management of bacterial meningitis and meningococcal septicaemia in children and young people younger than 16 years in primary and secondary care. London: NICE, 2010. http://www.nice.org.uk (accessed 29 Nov 2010).
13. Brouwer MC, Heckenberg SG, de Gans J, et al. Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology 2010;75:1533-9.
14. Chang CJ, Chang WN, Huang LT, et al. Cerebral infarction in perinatal and childhood bacterial meningitis. QJM 2003;96:755-62.
15. Drummond P, Clark J, Wheeler J, et al. Community acquired pneumonia - a prospective UK study. Arch Dis Child 2000;83:408-12.
16. Harris KA, Turner P, Green EA, et al. Duplex real-time PCR assay for detection of Streptococcus pneumoniae in clinical samples and determination of penicillin susceptibility. J Clin Microbiol 2008;46:2751-8.
17. Koshy E, Murray J, Bottle A, et al. Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997-2008. Thorax 2010;65:770-4.
18. Thomson AH, Hull J, Kumar MR, et al. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 2002;57:343-7. (Pubitemid 34298933)
19. Balfour-Lynn IM, Abrahamson E, Cohen G, et al.; Paediatric Pleural Diseases Subcommittee of the BTS Standards of Care Committee. BTS guidelines for the management of pleural infection in children. Thorax 2005;60(Suppl 1):i1-21.
20. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24. (Pubitemid 24082248)
21. Marshall R, Bellingan G, Laurent G. The acute respiratory distress syndrome: fibrosis in the fast lane. Thorax 1998;53:815-17. (Pubitemid 28459534)
22. Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective- ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998;338:347-54. (Pubitemid 28083906)
23. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342:1301-8.
24. Arnold JH, Hanson JH, Toro-Figuero LO, et al. Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med 1994;22:1530-9. (Pubitemid 24320874)
25. Peter JV, John P, Graham PL, et al. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 2008;336:1006-9. (Pubitemid 351656093)
26. Feikin DR, Schuchat A, Kolczak M, et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000;90:223-9. (Pubitemid 30062674)
27. Brierley J, Carcillo JA, Choong K, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 2009;37:666-88.
28. Han YY, Carcillo JA, Dragotta MA, et al. Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics 2003;112:793-9. (Pubitemid 37248685)
29. Inwald DP, Tasker RC, Peters MJ, et al.; Paediatric Intensive Care Society Study Group (PICS-SG). Emergency management of children with severe sepsis in the United Kingdom: the results of the Paediatric Intensive Care Society sepsis audit. Arch Dis Child 2009;94:348-53.
30. Waters AM, Kerecuk L, Luk D, et al. Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United Kingdom experience. J Pediatr 2007;151:140-4. (Pubitemid 47069411)
31. Copelovitch L, Kaplan BS. Streptococcus pneumoniae-associated hemolytic uremic syndrome. Pediatr Nephrol 2008;23:1951-6.
32. McGraw ME, Lendon M, Stevens RF, et al. Haemolytic uraemic syndrome and the Thomsen Friedenreich antigen. Pediatr Nephrol 1989;3:135-9. (Pubitemid 19100371)
33. Haghighat M, Dehghani SM, Alborzi A, et al. Organisms causing spontaneous bacterial peritonitis in children with liver disease and ascites in Southern Iran. World J Gastroenterol 2006;12:5890-2. (Pubitemid 44594261)
34. Ross JJ, Saltzman CL, Carling P, et al. Pneumococcal septic arthritis: review of 190 cases. Clin Infect Dis 2003;36:319-27. (Pubitemid 36169668)
35. Whitney CG, Farley MM, Hadler J, et al.; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-46. (Pubitemid 36514704)
36. Kaplan SL, Mason EO Jr, Wald ER, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 2004;113:443-9. (Pubitemid 38280781)
37. Pichon B, Moyce L, Efstratiou A, et al. Serotype replacement following the introduction of the PCV7 in the UK - impact on the characteristics of pneumococci causing meningitis. Health Protection Agency, 2009. http://www.hpa.org.uk (accessed 29 Nov 2010).
38. Kaye P, Malkani R, Martin S, et al. Invasive pneumococcal disease (IPD) in England and Wales after 7-valent conjugate vaccine (PCV7): potential impact of 10 and 13-valent vaccines. Health Protection Agency, 2009. http://www.hpa.org.uk (accessed 29 Nov 2010).
39. Albrich WC, Baughman W, Schmotzer B, et al. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine. Clin Infect Dis 2007;44:1569-76. (Pubitemid 46871503)
40. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007;297:1784-92. (Pubitemid 46658647)
41. Kaplan SL, Barson WJ, Lin PL, et al. Serotype 19A is the most common serotype causing invasive pneumococcal infections in children. Pediatrics 2010;125:429-36.
42. Department of Health. PL CPHO (2002)1: Extending meningitis C vaccine to 20-24 year olds: pneumococcal vaccine for at-risk 2 year olds. Department of Health, 2002. http://www.dh.gov.uk (accessed 29 Nov 2010).
43. Kaye P, Slack M, George R, et al. The impact of the introduction of Prevenar on pneumococcal disease in England and Wales. Health Protection Agency, 2008. http://www.hpa.org.uk (accessed 29 Nov 2010).